These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [HAART and changes of epidemiology, treatment and prognosis of HIV-positive patients with Kaposi's sarcoma and lymphoma].
    Author: Gabarre J, Bossi P.
    Journal: Bull Cancer; 2003 May; 90(5):419-25. PubMed ID: 12850765.
    Abstract:
    Highly active antiretroviral therapy (HAART) has changed the epidemiology of Kaposi's sarcoma (KS) and lymphoma occurring in people living with HIV. The KS's decrease was observed early after HAART availability: although delayed, the decrease of non Hodgkin lymphoma has been sign. The improvement of immune status due to HAART has decreased the occurrence of chemotherapy triggered opportunistic infections, and survival rates have been improved. The administration of chemotherapy with HAART does not seem to increase toxicity.
    [Abstract] [Full Text] [Related] [New Search]